Tian-cheng Wang
No. 139 Middle Renmin Road
Changsha, 410011, China
Changsha, 410011, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Intratumoral Fibrosis is a Potential Biomarker in Patients with Hepatocellular Carcinoma Undergoing Liver Resection.
Journal: Journal of hepatocellular carcinoma
Published: March 12, 2026
Skeletal muscle index/systemic immune-inflammation index (SMI/SII) ratio predicts prognosis in patients with hepatocellular carcinoma.
Journal: World journal of surgical oncology
Published: February 14, 2025
Subcutaneous adipose tissue/neutrophil-to-lymphocyte ratio is a potential biomarker in patients with hepatocellular carcinoma undergoing liver resection.
Journal: Science progress
Published: December 13, 2024
Combined Bone Mineral Density (BMD) and Monocyte-to-Lymphocyte Ratio (MLR) Predicts Recurrence and Prognosis in Hepatocellular Carcinoma Patients Following Liver Resection.
Journal: Risk management and healthcare policy
Published: June 11, 2024
CD36-mediated accumulation of MDSCs exerts abscopal immunosuppressive responses in hepatocellular carcinoma after insufficient microwave ablation.
Journal: Biochimica et biophysica acta. Molecular basis of disease
Published: March 21, 2024
Letter to the Editor: Intratumor fibrotic HCC, a subtype matching the Hoshida S1 subclass?
Journal: Hepatology (Baltimore, Md.)
Published: November 27, 2023
Prognostic Factors for Patients with Proliferative Hepatocellular Carcinoma After Liver Resection.
Journal: Journal of hepatocellular carcinoma
Published: September 16, 2023
Preoperative Systemic Immune-Inflammation Index is a Potential Biomarker in Adult Patients with High-Grade Gliomas Undergoing Radical Resection.
Journal: Journal of inflammation research
Published: June 20, 2023
Intraarterial Lidocaine Administration for Pain Control by Water-in-Oil Technique in Transarterial Chemoembolization: in vivo and Randomized Clinical Trial.
Journal: Journal of hepatocellular carcinoma
Published: August 05, 2021
Systemic Inflammation Response Index is a Prognostic Risk Factor in Patients with Hepatocellular Carcinoma Undergoing TACE.
Journal: Risk management and healthcare policy
Published: April 21, 2021
Development and Validation of a Predictive Model for Early Refractoriness of Transarterial Chemoembolization in Patients With Hepatocellular Carcinoma.
Journal: Frontiers in molecular biosciences
Published: November 25, 2020
A predictive model of incomplete response after transarterial chemoembolization for early or intermediate stage of hepatocellular carcinoma: consideration of hepatic angiographic and cross-sectional imaging.
Journal: Abdominal radiology (New York)
Published: May 18, 2020
Last Updated: 09/26/2026